| The cellular oncogene EWS/activating transcription factor 1 is unable to activate adenovirus-borne promoters: implications for cytotoxic prodrug therapy of malignant melanoma of soft parts. | skin, |
| Transcriptional activation by the Ewing s sarcoma (EWS) oncogene can be cis-repressed by the EWS RNA-binding domain. | sarcoma, |
| Characterization of a new brain-specific isoform of the EWS oncoprotein. | brain, |
| The Ewing s sarcoma oncoprotein EWS/FLI induces a p53-dependent growth arrest in primary human fibroblasts. | sarcoma, |
| The pro-oncoprotein EWS (Ewing s Sarcoma protein) interacts with the Brn-3a POU transcription factor and inhibits its ability to activate transcription. | sarcoma, |
| Expression of the EWS/FLI-1 oncogene in murine primary bone-derived cells Results in EWS/FLI-1-dependent, ewing sarcoma-like tumors. | sarcoma, |
| Association of the t(12;22)(q13;q12) EWS/ATF1 rearrangement with polyphenotypic round cell sarcoma of bone: a case report. | sarcoma, |
| There was evidence of EWS oncogene protein fusion in this sarcoma. | sarcoma, |
| Ewing s sarcoma oncoprotein EWS-FLI1: the perfect target without a therapeutic agent. | sarcoma, |
| Efficacy of siRNA nanocapsules targeted against the EWS-Fli1 oncogene in Ewing sarcoma. | sarcoma, |
| Caveolin-1 (CAV1) is a target of EWS/FLI-1 and a key determinant of the oncogenic phenotype and tumorigenicity of Ewing s sarcoma cells. | sarcoma, |
| NR0B1 is required for the oncogenic phenotype mediated by EWS/FLI in Ewing s sarcoma. | sarcoma, |
| EWS/FLI mediates transcriptional repression via NKX2.2 during oncogenic transformation in Ewing s sarcoma. | sarcoma, |
| A small molecule blocking oncogenic protein EWS-FLI1 interaction with RNA helicase A inhibits growth of Ewing s sarcoma. | sarcoma, |
| FOXO1 is a direct target of EWS-Fli1 oncogenic fusion protein in Ewing s sarcoma cells. | sarcoma, |
| a novel oncogenic mechanism in Ewing sarcoma, involving post-transcriptional derepression of IGF signaling by the EWS/Fli1 fusion oncoprotein via miRs | sarcoma, |
| A novel oncogenic mechanism in Ewing sarcoma involving IGF pathway targeting by EWS/Fli1-regulated microRNAs. | sarcoma, |
| Targeting the EWSR1-FLI1 oncogene-induced protein kinase PKC-beta abolishes ewing sarcoma growth. | sarcoma, |
| We found that transcriptional activation of PRKCB was directly regulated by the chimeric fusion oncogene EWSR1-FLI1 that drives ewing sarcoma growth. | sarcoma, |
| The EWS/FLI Oncogene Drives Changes in Cellular Morphology, Adhesion, and Migration in Ewing Sarcoma. | sarcoma, |